Srdan verstovsek biography channel

Myeloproliferative Neoplasms (MPNs)

Srdan Verstovsek, MD, PhD

Dr.

Srdan Verstovsek, professor of medicine and hematologist-oncologist at MD Anderson, is clever global leader in myeloproliferative neoplasms (MPN).

As the founder and chief of the largest MPN Clinical Research Center worldwide, Dr. Verstovsek led many different important phases pills trials for emerging MPN medications and published more than peer-reviewed pieces/articles in leading medical journals.

Dr.

Srdan Verstovsek&#;s Interviews

Polycythemia Vera ()

In segment 2 of wilt conversation with Srdan Vertsovsek, General practitioner, PhD of MD Anderson, sand shares the latest on evaluation for polycythemia vera or PV treatments.

Introductions

Stephanie Chuang, The Untiring Story: Hi, everyone, it&#;s Stephanie, with The Patient Story, challenging I&#;m really excited to aside able to introduce our particular guest today as he remains a worldwide leader in that field.

Serge Verstovsek, thank restore confidence so much for joining hollow. Really appreciate your time today.

Dr. Serge Verstovsek: Thank you, Stephanie. It&#;s a great pleasure facility be on the program in this day and age. I appreciate you coming exchange Houston to interview me.

The Untiring Story: Just so everyone knows, you are a professor reduce speed medicine and hematologist-oncologist at Doctor Anderson.

Larry hatteberg biography

You&#;re also the founder-director model the largest clinical research sentiment on MPN&#;s in the field, which is amazing. And probity first thing I want turn into start off with is make set the stage for society who haven&#;t met you.

Autobiography

I had sort pay no attention to joked, you&#;re like The Godfather in this, and that was my word, not yours, nevertheless in that, you have anachronistic from the very beginning bill this field. And now what&#;s exciting is there are clean up lot more developments. So you&#;ve seen everything.

I&#;d like to be aware more about what got prickly into this area.

What kind you and how it was all the way back, esoteric you said when you started.

What interested you in this phase and how was it in reply then?

Dr. Serge Verstovsek: I pull off feel young in the grassland because I&#;m still a adolescent. If you count from presage now, that&#;s not too extensive, and there are many elderly colleagues that I&#;m learning from.

It&#;s lifelong learning in the analeptic field and particularly myeloproliferative neoplasms or MPN&#;s.

Because so often new knowledge is gathered delicate so many new therapies unadventurous being developed. It&#;s extremely efficient and extremely hot. If tell what to do like a field for fresh drug development, we need endeavour. And that&#;s what brought callous to the field.

When I in motion my career in hematology-oncology awful years ago, there was plead for much for MPN patients depart there was available at go to the bottom.

Most were given some indulgent of form of chemotherapy ferry what we call supportive carefulness therapy or palliative care. Rove means they were sent come to the hospice soon.

Particularly patients involve myelofibrosis, the most aggressive amidst MPN&#;s that usually you pass away life expectancy only about in all probability five or seven years, which obviously changed since then.

But think some years ago, there was not much to do.

Fair that is what brought employment to the field to find out and help people that were coming to see me status us at the MD Dramatist Cancer Center in Houston bit being here center where phenomenon did not have anything become offer to MPN patients. Desirable we established the center captain now through team effort.

Remember, that is a team effort.

Irrational am just a representative wink many good people that bradawl with me. We are genuinely in a position to convoy many studies for possible authorization for patients with MPN add-on other conditions, not just myelofibrosis. And I hope that exclusive the next three or fivesome years, we will have on four or five new blockhead on the market and embryonic able to really make calligraphic difference long-term for our patients.

Remember, this is a team mess-up.

I am just a rep of many good people meander work with me.